Buscador de ensayos clínicos de Fight CRC
NCT ID | Title | Fase | Date Added | Ubicación | Prior IO Allowed | CRC-directed | Status | Drogas | Etiquetas |
---|---|---|---|---|---|---|---|---|---|
NCT ID NCT03096093 |
TitleInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer | Fase
Phase 1, Phase 2
|
Date Added 2017-03-30 |
Ubicación
Reino Unido
|
Prior IO Allowed Sí |
CRC-directed No |
Status
Activo, no recluta
|
Drogas
ACIT-1 |
Etiquetas
MSS/ MMRp
|
NCT ID NCT04130854 |
TitleINNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | Fase
Fase 2
|
Date Added 2019-10-18 |
Ubicación
Arizona, United States
North Carolina, United States Oregon, United States Texas, United States |
Prior IO Allowed No |
CRC-directed Sí |
Status
Activo, no recluta
|
Drogas
APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and Radiation Therapy 5Gy x 5 days |
Etiquetas
MSS/ MMRp
|
NCT ID NCT05611034 |
TitleIn Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung | Fase
Fase 1
|
Date Added 2022-11-09 |
Ubicación
Canadá
|
Prior IO Allowed Sí |
CRC-directed Sí |
Status
Reclutamiento
|
Drogas
oxaliplatin |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT05299840 |
TitleImpact of Using the Oncogramme(R) Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer | Fase
No aplicable
|
Date Added 2022-03-29 |
Ubicación
Francia
|
Prior IO Allowed No |
CRC-directed Sí |
Status
Reclutamiento
|
Drogas |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT01174121 |
TitleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | Fase
Fase 2
|
Date Added 2010-08-03 |
Ubicación
Maryland, United States
|
Prior IO Allowed Sí |
CRC-directed Sí |
Status
Reclutamiento
|
Drogas
Aldesleukin, Cyclophosphamide, Fludarabine, Pembrolizumab (Keytruda), Young TIL |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT04444622 |
TitleImmunotherapy for Third Line Metastatic Colorectal Cancer | Fase
Fase 2
|
Date Added 2020-06-23 |
Ubicación
Florida, United States
Michigan, United States New Jersey, United States New York, United States |
Prior IO Allowed No |
CRC-directed Sí |
Status
Activo, no recluta
|
Drogas |
Etiquetas
MSS/ MMRp
|
NCT ID NCT03658785 |
TitleInmunoterapia para el tratamiento de tumores sólidos avanzados | Fase
Fase 1
|
Date Added 2018-09-05 |
Ubicación
China
|
Prior IO Allowed Sí |
CRC-directed No |
Status
Reclutamiento
|
Drogas
Aldesleukin, Cyclophosphamide, Fludarabine, TIL |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT06515314 |
TitleHRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors | Fase
Fase 1
|
Date Added 2024-07-23 |
Ubicación
China
|
Prior IO Allowed Sí |
CRC-directed No |
Status
Reclutamiento
|
Drogas |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT03366155 |
TitleHepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver | Fase
Fase 2
|
Date Added 2017-12-08 |
Ubicación
Maryland, United States
|
Prior IO Allowed No |
CRC-directed Sí |
Status
Activo, no recluta
|
Drogas
5FU, cetuximab, FUDR-Dex, Irinotecan, Medtronic SynchroMed II Pump with Codman 3000 Constant Flow Pump Catheter, OneRNA, oxaliplatin, panitumumab |
Etiquetas
MSI-H/ MMRd, MSS/ MMRp
|
NCT ID NCT06558773 |
TitleGSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. | Fase
Fase 2
|
Date Added 2024-08-19 |
Ubicación
China
|
Prior IO Allowed Sí |
CRC-directed Sí |
Status
Aún no se ha contratado
|
Drogas |
Etiquetas
MSS/ MMRp
|